Genetic Disorder News and Research

RSS
Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Epigenetic switch can cause cancer, shows study

Epigenetic switch can cause cancer, shows study

Deleting enzyme favorably impacts behaviors associated with autistic behaviors

Deleting enzyme favorably impacts behaviors associated with autistic behaviors

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

FDA approves Ryanodex for treatment of malignant hyperthermia linked with anesthesia

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Researchers identify group of cells in brain that plays important role in Down syndrome

Researchers identify group of cells in brain that plays important role in Down syndrome

Scientists reveal structure of protein involved in life and development of cancer

Scientists reveal structure of protein involved in life and development of cancer

Isis earns $1 million payment from GSK related to advancement of ISIS-TTRRx

Isis earns $1 million payment from GSK related to advancement of ISIS-TTRRx

New hope for patients with tuberous sclerosis complex

New hope for patients with tuberous sclerosis complex

New approach for developing personalized gene therapies to treat retinitis pigmentosa

New approach for developing personalized gene therapies to treat retinitis pigmentosa

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Leading hypothesis for miscarriages, birth defects ruled out by WSU reproductive biologists

Leading hypothesis for miscarriages, birth defects ruled out by WSU reproductive biologists

FDA grants Fast Track designation to Akashi Therapeutics' HT-100 for treatment of DMD

FDA grants Fast Track designation to Akashi Therapeutics' HT-100 for treatment of DMD

New gene therapy for Acute Intermittent Porphyria

New gene therapy for Acute Intermittent Porphyria

NEI researchers describe functions of gene responsible for anchoring cilia

NEI researchers describe functions of gene responsible for anchoring cilia

UCLA receives $7.2 million grant to develop ways to diagnose rare genetic disorders

UCLA receives $7.2 million grant to develop ways to diagnose rare genetic disorders

MedicAlert Foundation announces free medical IDs for individuals living with Malignant Hyperthermia

MedicAlert Foundation announces free medical IDs for individuals living with Malignant Hyperthermia

University of Utah researcher to receive Nelson Trust Award for Retinitis Pigmentosa

University of Utah researcher to receive Nelson Trust Award for Retinitis Pigmentosa

State roundup: Troubles in Kentucky; MD. hospital under review

State roundup: Troubles in Kentucky; MD. hospital under review

Cancer drug shows promise in treating blood cell disorders

Cancer drug shows promise in treating blood cell disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.